Skip to search formSkip to main contentSkip to account menu

dynorphin A-analogue kappa ligand

Known as: DAKLI, Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Arg-Leu-Arg-Gly 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effective Ways of Assessment Which Motivate Students Nowadays (Case Study: “Ahmet Dakli” High School, Elbasan-Albania)
<jats:p>0</jats:p> 
1998
1998
Effetti di un agonista oppioide (DAKLI) sul rilascio di cortisolo nella pecora - 52, 67-68, Silvi Marina, 1998
1998
1998
Effects of μ-, δ-, and κ-opioid agonists and enkephalinase inhibitor RB101 in two inbred rat strains
Analgesic and suppressive effects of selective μ- (DAGO), δ- (DME), and κ- (DAKLI) opioid agonists are compared with those of… 
1994
1994
Technical aspects of opioid receptor localization: detection of opioid receptor proteins by immunocytochemistry or with a biotinylated dynorphin analog
1993
1993
Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release.
The mechanisms for the antidiuretic effects of dynorphin (DYN), an endogenous kappa-agonist, microinjected into the hypothalamic… 
1993
1993
Centrally administered μ- and δ-opioid agonists increase operant responding for saccharin
1990
1990
Opioid and non-opioid behavioral actions of dynorphin A and the dynorphin analogue DAKLI.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)